Theriva Biologics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -21.8% | -21.8% | -20.3% |
| FY2022 | -38.0% | -37.8% | -27.4% |
| FY2023 | -49.6% | -49.4% | -33.2% |
| FY2024 | -134.5% | -133.9% | -72.6% |
| FY2025 | -154.3% | -139.2% | -62.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -21.8% | -21.8% | -20.3% |
| FY2022 | -38.0% | -37.8% | -27.4% |
| FY2023 | -49.6% | -49.4% | -33.2% |
| FY2024 | -134.5% | -133.9% | -72.6% |
| FY2025 | -154.3% | -139.2% | -62.1% |